Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Gut

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Withdrawals due to adverse outcomes · Patients with active Crohn's disease

Low dose naltrexone showed no clear difference in withdrawals due to adverse outcomes compared with placebo (low certainty).

1 finding from 1 review

Low dose naltrexone for induction of remission in Crohn's disease 2018 · Cochrane Headline outcomes only
RR 1.57 [0.23, 10.71]
2 studies · 46 participants
Low